Skip to main content
Top
Published in: Journal of Neurology 4/2012

01-04-2012 | Original Communication

Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson’s disease

Authors: Stina Bladh, Maria H. Nilsson, Gun-Marie Hariz, Albert Westergren, Jeremy Hobart, Peter Hagell

Published in: Journal of Neurology | Issue 4/2012

Login to get access

Abstract

Walking difficulties are common in neurological and other disorders, as well as among the elderly. There is a need for reliable and valid instruments for measuring walking difficulties in everyday life since existing gait tests are clinician rated and focus on situation specific capacity. The Walk-12G was adapted from the 12-item multiple sclerosis walking scale as a generic patient-reported rating scale for walking difficulties in everyday life. The aim of this study is to examine the psychometric properties of the Walk-12G in people with multiple sclerosis (MS) and Parkinson’s disease (PD). The Walk-12G was translated into Swedish and evaluated qualitatively among 25 people with and without various neurological and other conditions. Postal survey (MS, n = 199; PD, n = 189) and clinical (PD, n = 36) data were used to test its psychometric properties. Respondents considered the Walk-12G relevant and easy to use. Mean completion time was 3.5 min. Data completeness was good (<5% missing item responses) and tests of scaling assumptions supported summing item scores to a total score (corrected item-total correlations >0.6). Coefficient alpha and test–retest reliabilities were >0.9, and standard errors of measurement were 2.3–2.8. Construct validity was supported by correlations in accordance with a priori expectations. Results are similar to those with previous Walk-12G versions, indicating that scale adaptation was successful. Data suggest that the Walk-12G meets rating scale criteria for clinical trials, making it a valuable complement to available gait tests. Further studies involving other samples and application of modern psychometric methods are warranted to examine the scale in more detail.
Literature
1.
go back to reference Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, Nyland HI (2001) Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 7(1):59–65PubMed Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, Nyland HI (2001) Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 7(1):59–65PubMed
2.
go back to reference Schrag A, Ben-Shlomo Y, Quinn N (2002) How common are complications of Parkinson’s disease? J Neurol 249(4):419–423PubMedCrossRef Schrag A, Ben-Shlomo Y, Quinn N (2002) How common are complications of Parkinson’s disease? J Neurol 249(4):419–423PubMedCrossRef
3.
go back to reference Martinez-Martin P, Garcia Urra D, del Ser Quijano T, Balseiro Gomez J, Gomez Utrero E, Pineiro R, Andres MT (1997) A new clinical tool for gait evaluation in Parkinson’s disease. Clin Neuropharmacol 20(3):183–194PubMedCrossRef Martinez-Martin P, Garcia Urra D, del Ser Quijano T, Balseiro Gomez J, Gomez Utrero E, Pineiro R, Andres MT (1997) A new clinical tool for gait evaluation in Parkinson’s disease. Clin Neuropharmacol 20(3):183–194PubMedCrossRef
4.
go back to reference Shumway-Cook A, Woollacott M (2007) Motor control: translating research into clinical practice. Lippincott Williams and Wilkins, Baltimore Shumway-Cook A, Woollacott M (2007) Motor control: translating research into clinical practice. Lippincott Williams and Wilkins, Baltimore
5.
go back to reference Thomas M, Jankovic J, Suteerawattananon M, Wankadia S, Caroline KS, Vuong KD, Protas E (2004) Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci 217(1):89–99PubMedCrossRef Thomas M, Jankovic J, Suteerawattananon M, Wankadia S, Caroline KS, Vuong KD, Protas E (2004) Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci 217(1):89–99PubMedCrossRef
6.
go back to reference Department of Health (2008) High quality care for all–NHS Next Stage Review Final Report. Department of Health, UK Department of Health (2008) High quality care for all–NHS Next Stage Review Final Report. Department of Health, UK
7.
go back to reference Food and Drug Administration (2009) Patient-Reported Outcome measures: Use in Medicinal Product Development to Support Labelling Claims. Washington DC Food and Drug Administration (2009) Patient-Reported Outcome measures: Use in Medicinal Product Development to Support Labelling Claims. Washington DC
8.
go back to reference Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2003) Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 60(1):31–36PubMed Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2003) Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 60(1):31–36PubMed
9.
go back to reference Holland A, O’Connor RJ, Thompson AJ, Playford ED, Hobart JC (2006) Talking the talk on walking the walk: a 12-item generic walking scale suitable for neurological conditions? J Neurol 253(12):1594–1602PubMedCrossRef Holland A, O’Connor RJ, Thompson AJ, Playford ED, Hobart JC (2006) Talking the talk on walking the walk: a 12-item generic walking scale suitable for neurological conditions? J Neurol 253(12):1594–1602PubMedCrossRef
10.
go back to reference Hobart J (2011) The Multiple Sclerosis Impacts Scale (MSIS-29): Initial development; subsequent revision; lessons learned. In: Jenkinson C, Peters M, Bromberg MB (eds) Quality of Life Measurement in Neurodegenerative and Related Conditions. Cambridge University Press, Cambridge, pp 24–40CrossRef Hobart J (2011) The Multiple Sclerosis Impacts Scale (MSIS-29): Initial development; subsequent revision; lessons learned. In: Jenkinson C, Peters M, Bromberg MB (eds) Quality of Life Measurement in Neurodegenerative and Related Conditions. Cambridge University Press, Cambridge, pp 24–40CrossRef
11.
go back to reference Swaine-Verdier A, Doward LC, Hagell P, Thorsen H, McKenna SP (2004) Adapting quality of life instruments. Value Health 7(Suppl 1):S27–S30PubMedCrossRef Swaine-Verdier A, Doward LC, Hagell P, Thorsen H, McKenna SP (2004) Adapting quality of life instruments. Value Health 7(Suppl 1):S27–S30PubMedCrossRef
12.
go back to reference Fahn S, Elton RL (1987) Members of the UPDRS development committee Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. MacMillan Healthcare Information, Florham Park, pp 153–163 Fahn S, Elton RL (1987) Members of the UPDRS development committee Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. MacMillan Healthcare Information, Florham Park, pp 153–163
13.
go back to reference Hagell P, Törnqvist AL, Hobart J (2008) Testing the SF-36 in Parkinson’s disease: Implications for reporting rating scale data. J Neurol 255(2):246–254PubMedCrossRef Hagell P, Törnqvist AL, Hobart J (2008) Testing the SF-36 in Parkinson’s disease: Implications for reporting rating scale data. J Neurol 255(2):246–254PubMedCrossRef
14.
go back to reference Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 71(3):363–370PubMedCrossRef Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 71(3):363–370PubMedCrossRef
15.
go back to reference Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124(Pt 5):962–973PubMedCrossRef Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 124(Pt 5):962–973PubMedCrossRef
16.
go back to reference Hobson JP, Edwards NI, Meara RJ (2001) The Parkinson’s disease activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson’s disease. Clin Rehabil 15(3):241–246PubMedCrossRef Hobson JP, Edwards NI, Meara RJ (2001) The Parkinson’s disease activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson’s disease. Clin Rehabil 15(3):241–246PubMedCrossRef
17.
go back to reference Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452PubMed
18.
go back to reference Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G (2005) Measuring gait and gait-related activities in Parkinson’s patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord 11(1):19–24PubMedCrossRef Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G (2005) Measuring gait and gait-related activities in Parkinson’s patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord 11(1):19–24PubMedCrossRef
19.
go back to reference Louis ED, Lynch T, Marder K, Fahn S (1996) Reliability of patient completion of the historical section of the Unified Parkinson’s Disease Rating Scale. Mov Disord 11(2):185–192PubMedCrossRef Louis ED, Lynch T, Marder K, Fahn S (1996) Reliability of patient completion of the historical section of the Unified Parkinson’s Disease Rating Scale. Mov Disord 11(2):185–192PubMedCrossRef
20.
go back to reference McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand’Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ (2010) International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS). Value Health 13(8):946–951PubMedCrossRef McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand’Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ (2010) International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS). Value Health 13(8):946–951PubMedCrossRef
22.
go back to reference Nilsson MH, Hariz GM, Wictorin K, Miller M, Forsgren L, Hagell P (2010) Development and testing of a self administered version of the Freezing of Gait Questionnaire. BMC neurology 10:85PubMedCrossRef Nilsson MH, Hariz GM, Wictorin K, Miller M, Forsgren L, Hagell P (2010) Development and testing of a self administered version of the Freezing of Gait Questionnaire. BMC neurology 10:85PubMedCrossRef
23.
go back to reference Ware JE Jr, Gandek B (1998) Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 51(11):945–952PubMedCrossRef Ware JE Jr, Gandek B (1998) Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 51(11):945–952PubMedCrossRef
24.
go back to reference Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13 (12):iii, ix–x, 1–177 Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13 (12):iii, ix–x, 1–177
25.
go back to reference O’Connor BP (2000) SPSS and SAS programs for determining the number of components using parallel analysis and velicer’s MAP test. Behav Res Methods Instrum Comput 32(3):396–402PubMedCrossRef O’Connor BP (2000) SPSS and SAS programs for determining the number of components using parallel analysis and velicer’s MAP test. Behav Res Methods Instrum Comput 32(3):396–402PubMedCrossRef
26.
go back to reference McGuigan C, Hutchinson M (2004) Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology 62(11):2103–2105PubMed McGuigan C, Hutchinson M (2004) Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology 62(11):2103–2105PubMed
27.
go back to reference Motl RW, Snook EM (2008) Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12). J Neurol Sci 268(1–2):69–73PubMedCrossRef Motl RW, Snook EM (2008) Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12). J Neurol Sci 268(1–2):69–73PubMedCrossRef
28.
go back to reference Baron R, Elashaal A, Germon T, Hobart J (2006) Measuring outcomes in cervical spine surgery: think twice before using the SF-36. Spine 31(22):2575–2584PubMedCrossRef Baron R, Elashaal A, Germon T, Hobart J (2006) Measuring outcomes in cervical spine surgery: think twice before using the SF-36. Spine 31(22):2575–2584PubMedCrossRef
29.
go back to reference Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14(2):285–295PubMedCrossRef Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14(2):285–295PubMedCrossRef
30.
go back to reference Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373(9665):732–738PubMedCrossRef Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373(9665):732–738PubMedCrossRef
31.
go back to reference Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press Inc., New York Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press Inc., New York
32.
go back to reference Nilsson MH, Hagell P (2009) Freezing of Gait Questionnaire: validity and reliability of the Swedish version. Acta Neurol Scand 120(5):331–334PubMedCrossRef Nilsson MH, Hagell P (2009) Freezing of Gait Questionnaire: validity and reliability of the Swedish version. Acta Neurol Scand 120(5):331–334PubMedCrossRef
33.
go back to reference Wann-Hansson C, Klevsgard R, Hagell P (2008) Cross-diagnostic validity of the Nottingham Health Profile Index of Distress (NHPD). Health Qual Life Outcomes 6:47PubMedCrossRef Wann-Hansson C, Klevsgard R, Hagell P (2008) Cross-diagnostic validity of the Nottingham Health Profile Index of Distress (NHPD). Health Qual Life Outcomes 6:47PubMedCrossRef
Metadata
Title
Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson’s disease
Authors
Stina Bladh
Maria H. Nilsson
Gun-Marie Hariz
Albert Westergren
Jeremy Hobart
Peter Hagell
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 4/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6254-z

Other articles of this Issue 4/2012

Journal of Neurology 4/2012 Go to the issue